Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
SHANK3 (also known as ProSAP2) regulates the structural organization of dendritic spines and is a binding partner of neuroligins; genes encoding neuroligins are mutated in autism and Asperger syndrome. Here, we report that a mutation of a single copy of SHANK3 on chromosome 22q13 can result in language and/or social communication disorders. These mutations concern only a small number of individuals, but they shed light on one gene dosage-sensitive synaptic pathway that is involved in autism spectrum disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss of a functional copy of the SHANK3 gene leads to the neurobehavioral manifestations of 22q13 deletion syndrome and/or to autism spectrum disorders.”
From Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication (2010) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The variations identified included de novo deleterious mutations and inherited non-synonymous variations affecting highly conserved amino acids in the ankyrin domain.6, 7”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The remaining three mutations are non-synonymous mutations located in or near the highly conserved ankyrin domain (R12C, R300C and Q321R, referred to as Shank3R12C, Shank3R300C and Shank3Q321R, respectively).6, 7”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent human genetic studies indicate that SHANK family genes (SHANK1, SHANK2, and SHANK3) are causative genes for idiopathic autism spectrum disorders (ASD).”
From Modeling Autism by SHANK Gene Mutations in Mice (2013) · cites this paper as Durand et al., 2007
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In three families from France and Canada, the SHANK3 deletions originated from a balanced translocation present in a healthy parent [6], [13].”
From Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments (2014) · cites this paper as [6]
Experimental — accuracy not yet measured
21 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A forkhead-domain gene is mutated in a severe speech and language disorder
Lai, C. S. L., Fisher, S. E., Hurst, J. A., Vargha-Khadem, F., & Monaco, A. P. (2001) · Nature · doi:10.1038/35097076 · Cited by 2,054
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
Study, P. A. R. I. S., Jamain, S., Quach, H., Betancur, C., Råstam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1136 · Cited by 1,851
Self-citationNaisbitt, S., Kim, E., Tu, J. C., Xiao, B., Sala, C., Valtschanoff, J., Weinberg, R. J., Worley, P. F., & Sheng, M. (1999) · Neuron · doi:10.1016/s0896-6273(00)80809-0 · Cited by 1,009
Genetics of austim: complex aetiology for a heterogeneous disorder
Folstein, S. E., & Rosen-Sheidley, B. (2001) · Nature Reviews Genetics · doi:10.1038/35103559 · Cited by 771
Searching for ways out of the autism maze: genetic, epigenetic and environmental clues
Persico, A. M., & Bourgeron, T. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.05.010 · Cited by 575
Self-citationVorstman, J. A. S., Staal, W. G., van Daalen, E., van Engeland, H., Hochstenbach, P. F. R., & Franke, L. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001757 · Cited by 353
Spine architecture and synaptic plasticity
Carlisle, H. J., & Kennedy, M. B. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.01.008 · Cited by 350
Boeckers, T. M., Bockmann, J., Kreutz, M. R., & Gundelfinger, E. D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00931.x · Cited by 349
Self-citationSevere Expressive-Language Delay Related to Duplication of the Williams–Beuren Locus
Somerville, M. J., Mervis, C. B., Young, E. J., Seo, E.-J., del Campo, M., Bamforth, S., Peregrine, E., Loo, W., Lilley, M., Pérez-Jurado, L. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051962 · Cited by 312
Bonaglia, M. C., Giorda, R., Borgatti, R., Felisari, G., Gagliardi, C., Selicorni, A., & Zuffardi, O. (2001) · The American Journal of Human Genetics · doi:10.1086/321293 · Cited by 309
Cited by
Items 701–800 of 1,004
A kinome-wide RNAi screen identifies ERK2 as a druggable regulator of Shank3 stability
Wang, L., Adamski, C. J., Bondar, V. V., Craigen, E., Collette, J. R., Pang, K., Han, K., Jain, A., Jung, S. Y., Liu, Z., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0325-9 · Cited by 32
Dissecting the Genetics of Autism Spectrum Disorders: A Drosophila Perspective
Bellosta, P., & Soldano, A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00987 · Cited by 35
Individual differences in stereotypy and neuron subtype translatome with TrkB deletion
Engeln, M., Song, Y., Chandra, R., La, A. M., Fox, M. E., Evans, B., Turner, M. D., Thomas, S., Francis, T. C., Hertzano, R. P., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0746-0 · Cited by 26
The role of neuroglia in autism spectrum disorders
Scuderi, C., & Verkhratsky, A. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.04.011 · Cited by 31
A systematic review of common genetic variation and biological pathways in autism spectrum disorder
Rodríguez-Gomez, D. A., García-Guáqueta, D. P., Charry-Sánchez, J. D., Sarquis-Buitrago, E., Blanco, M., Vélez-van-Meerbeke, A., & Talero‐Gutiérrez, C. (2021) · BMC Neuroscience · doi:10.1186/s12868-021-00662-z · Cited by 40
“Interactions between presynaptic NRXNs and postsynaptic NLGNs mediate trans-synaptic cell adhesion and shape synaptic efficacy and plasticity [69].”
BackgroundInfluentialModelling behaviors relevant to brain disorders in the nonhuman primate: Are we there yet?
Scott, J. T., & Bourne, J. A. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102183 · Cited by 31
Meta-analysis of epigenome-wide association studies of major depressive disorder
Li, Q. S., Morrison, R. L., Turecki, G., & Drevets, W. C. (2022) · Scientific Reports · doi:10.1038/s41598-022-22744-6 · Cited by 44
Sadino, J. M., Bradeen, X., Kelly, C. J., Brusman, L. E., Walker, D. M., & Donaldson, Z. R. (2023) · eLife · doi:10.7554/elife.80517 · Cited by 31
“GO terms associated with these genes include adult walking behavior, a term that contains the autism-associated gene Shank3 ( Figure 4G ; Gong et al., 2015 ; Durand et al., 2007 ).”
BackgroundAziz, A., Harrop, S. P., & Bishop, N. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014547 · Cited by 38
“of the genes implicated in ASD have direct or indirect roles in synapse formation and function [13–19].”
BackgroundLinkage and linkage disequilibrium scan for autism loci in an extended pedigree from Finland
Kilpinen, H., Ylisaukko‐oja, T., Rehnström, K., Gaál, E. I., Turunen, J. A., Kempas, E., von Wendt, L., Varilo, T., & Peltonen, L. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp229 · Cited by 35
“These and some more recent findings, such as identification of mutations in the neuroligin genes (12,13), SHANK3 (14,15) and CNTNAP2 (16–19) point out that rare high-penetrance mutations may be causative for the autistic phenotype.”
Enlarged dendritic spines and pronounced neophobia in mice lacking the PSD protein RICH2
Sarowar, T., Grabrucker, S., Föhr, K., Mangus, K., Eckert, M., Bockmann, J., Boeckers, T. M., & Grabrucker, A. M. (2016) · Molecular Brain · doi:10.1186/s13041-016-0206-6 · Cited by 30
Self-citationNeurobiology and treatment of social cognition in schizophrenia: Bridging the bed-bench gap
Kimoto, S., Makinodan, M., & Kishimoto, T. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.10.022 · Cited by 34
Nervous vascular parallels: axon guidance and beyond
Arese, M., Serini, G., & Bussolino, F. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103242ma · Cited by 37
The effect of perceptual-motor training on attention in the children with autism spectrum disorders
Afshari, J. (2012) · Research in Autism · doi:10.1016/j.rasd.2012.05.003 · Cited by 39
Impact of human pathogenic micro-insertions and micro-deletions on post-transcriptional regulation
Zhang, X., Lin, H., Zhao, H., Hao, Y., Mort, M. E., Cooper, D. N., Zhou, Y., & Liu, Y. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu019 · Cited by 34
“75) was composed of the following seven features: (1) distance to splice donor site, (2) distance to splice acceptor site, (3) GC content of mutated sequences, (4) disruption of the RNA secondary structure, (5) conservation score, (6) maximal magnitude of RBPs binding changes by an INDEL and (7) the number of RBPs who…”
BackgroundOkamoto, N., Hatsukawa, Y., Shimojima, K. Y., & Yamamoto, T. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34028 · Cited by 33
“…candidate genes have implicated the synaptic genes NLGN3(Neuroligin3 OMIM*300336), NLGN4 (OMIM*300427) [Jamain et al., 2003], SHANK3 (OMIM*606230)[Durand et al., 2007; Moessner et al., 2007], NRXN1(Neurexin1 MIMþ 600565) [Kim et al., 2008], SHANK2 (OMIM*603290) [Berkel et al., 2010], and CNTNAP2…”
Jiang, D., Wu, Z., Forsyth, C., Hu, Y., Yee, S., & Chen, G. (2018) · Molecular Brain · doi:10.1186/s13041-018-0375-6 · Cited by 31
“Mutations in proteins interacting with neuroligins such as Neurexin1, SHANK and MDGA have also been associated with autism and schizophrenia patients [6, 13, 31, 32].”
BackgroundA multiscale analysis in CD38 −/− mice unveils major prefrontal cortex dysfunctions
Martucci, L. L., Amar, M., Chaussenot, R., Benet, G., Bauer, O., de Zélicourt, A., Nosjean, A., Launay, J., Callebert, J., Sebrié, C., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201800489r · Cited by 33
Husson, T., Lecoquierre, F., Cassinari, K., Charbonnier, C., Quenez, O., Goldenberg, A., Guerrot, A., Richard, A., Drouin‐Garraud, V., Bréhin, A., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0760-7 · Cited by 40
Molecular architecture of postsynaptic Interactomes
Wilkinson, B., & Coba, M. P. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109782 · Cited by 30
Zhang, F., Rein, B. A., Zhong, P., Shwani, T., Conrow‐Graham, M., Wang, Z., & Yan, Z. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01233-w · Cited by 35
Desarkar, P., Rajji, T. K., Ameis, S. H., Blumberger, D. M., Lai, M., Lunsky, Y., & Daskalakis, Z. J. (2021) · Clinical Neurophysiology · doi:10.1016/j.clinph.2021.03.046 · Cited by 35
Kupferschmidt, D. A., Cummings, K. A., Joffe, M. E., MacAskill, A. F., Malik, R., Sánchez-Bellot, C., Tejeda, H. A., & Yarur, H. E. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1136-22.2022 · Cited by 30
“Likewise, a loss-of-function mutation in the autism-associated Shank3 gene (Durand et al., 2007) was recently shown to reduce dendritic inhibition onto mPFC pyramidal neurons via decreased NMDAR currents in, and reduced firing of, SST-INs (Ali et al., 2021).”
BackgroundModeling autism spectrum disorders with human neurons
Beltrão-Braga, P. C. B., & Muotri, A. R. (2016) · Brain Research · doi:10.1016/j.brainres.2016.01.057 · Cited by 44
“, 2003), resulting in loss of genes, such as SHANK3, a protein in excitatory synapses that have been associated with autism (Durand et al., 2007).”
Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date
Fung, L. K., & Hardan, A. Y. (2015) · CNS Drugs · doi:10.1007/s40263-015-0252-0 · Cited by 29
Evidence for involvement of GNB1L in autism
Chen, Y., Matsushita, M. M., Girirajan, S., Lisowski, M., Sun, E., Sul, Y., Bernier, R., Estes, A. M., Dawson, G., Minshew, N. J., et al. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32002 · Cited by 30
“…of missense mutations in a number of genes, including NLGN3 (MIM 300336) and NLGN4 (MIM 300427) [Jamain et al., 2003],NRXN1 (MIM 600565) [Kim et al., 2008], SHANK3 (MIM 606230) [Durand et al., 2007], SHANK2 (MIM 603290) [Berkel et al., 2010], and CNTNAP2 (MIM 604569) [Bakkaloglu et al., 2008].”
The role of rare structural variants in the genetics of autism spectrum disorders
Kusenda, M., & Sebat, J. L. (2008) · Cytogenetic and Genome Research · doi:10.1159/000184690 · Cited by 34
“, 2004) and Shank3 (Durand et al., 2007).”
Autism Spectrum Disorders, Risk Communication, and the Problem of Inadvertent Harm
Rossi, J. P., Newschaffer, C. J., & Yudell, M. (2013) · Kennedy Institute of Ethics journal · doi:10.1353/ken.2013.0006 · Cited by 32
Is insulin growth factor-1 the future for treating autism spectrum disorder and/or schizophrenia?
Khalil, R. B. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.12.004 · Cited by 31
Hartwig, C. L., Monis, W. J., Chen, X., Dickman, D. K., Pazour, G. J., & Faúndez, V. (2017) · Developmental Neurobiology · doi:10.1002/dneu.22542 · Cited by 31
“The 22q13 duplication associates with a range of neurodevelopmental disorders from Asperger syndrome, attention deficit-hyperactivity disorder, to schizophrenia (Durand et al., 2007; Failla et al., 2007; Moessner et al., 2007; Rahikkala et al., 2013; Ahn et al., 2014).”
BackgroundStephan, D. A. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.12.003 · Cited by 31
Phospholipase Cβlb associates with a Shank3 complex at the cardiac sarcolemma
Grubb, D. R., Iliades, P., Cooley, N., Yu, Y. L., Luo, J., Filtz, T. M., & Woodcock, E. A. (2010) · The FASEB Journal · doi:10.1096/fj.10-171470 · Cited by 33
“der (31, 32) and have been associated with schizophre-”
Genome-Wide Association Studies of Autism
Glessner, J., Connolly, J. J., & Hakonarson, H. H. (2014) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-014-0023-0 · Cited by 28
Meta-analysis of differentially expressed genes in autism based on gene expression data
Ning, L., Yu, Y., GuoJi, E. T., Kou, C., Wu, Y., Shi, J., Ai, L., & Yu, Q. (2015) · Genetics and Molecular Research · doi:10.4238/2015.march.27.1 · Cited by 28
“…nervous system (e.g., OXTR, SLC6A4, GABRB3, and SHANK3), and regulation of neuronal activity (e.g., FMR1, MECP2, and UBE3A) (Ingram et al., 2000; Martin et al., 2000; Wassink et al., 2001; Jamain et al., 2002; Campbell et al., 2006; Hu et al., 2006; Talebizadeh et al., 2006; Durand et al., 2007).”
BackgroundMa, S. L., Chen, L. H., Lee, C., Lai, K. Y. C., Hung, S., Tang, C.-P., Ho, T., Shea, C. K., Mo, F. Y. M., Mak, T. S. H., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.649588 · Cited by 33
“First, paternal balanced translocation of SHANK3 was reported to result in both ASD and ADHD (Durand et al., 2007; Moessner et al., 2007).”
BackgroundInfluentialA convergent mechanism of high risk factors ADNP and POGZ in neurodevelopmental disorders
Conrow‐Graham, M., Williams, J. B., Martin, J. A., Zhong, P., Cao, Q., Rein, B. A., & Yan, Z. (2022) · Brain · doi:10.1093/brain/awac152 · Cited by 29
“28,29,53,54 Some ASD/ID monogenic variants contribute directly to synapse formation or function 32,41,55 ; however, many others, including ADNP and POGZ, are involved in the regulation of gene expression.”
BackgroundThe Use of Induced Pluripotent Stem Cell Technology to Advance Autism Research and Treatment
Acab, A., & Muotri, A. R. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0354-x · Cited by 33
Subacute Neuropsychiatric Syndrome in Girls WithSHANK3Mutations Responds to Immunomodulation
Bey, A. L., Gorman, M., Gallentine, W. B., Kohlenberg, T. M., Frankovich, J., Jiang, Y., & van Haren, K. P. (2020) · PEDIATRICS · doi:10.1542/peds.2019-1490 · Cited by 29
Key Synaptic Pathology in Autism Spectrum Disorder: Genetic Mechanisms and Recent Advances
Zhang, Y., Tang, R., Hu, Z., Wang, X., Gao, X., Wang, T., & Tang, M. X. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2310184 · Cited by 32
Rizk, M., Saker, Z., Harati, H., Fares, Y., Bahmad, H. F., & Nabha, S. M. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06237-9 · Cited by 31
Zinc deficiency and supplementation in autism spectrum disorder and Phelan‐McDermid syndrome
Alsufiani, H. M., Alkhanbashi, A. S., Laswad, N. A. B., Bakhadher, K. K., AlGhamdi, S. A., Tayeb, H. O., & Tarazi, F. I. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25019 · Cited by 30
Pescosolido, M. F., Yang, U., Sabbagh, M. F., & Morrow, E. M. (2012) · Dialogues in Clinical Neuroscience · doi:10.1080/19585969.2022.12130883 · Cited by 34
A review of ultrasonic vocalizations in mice and how they relate to human speech
Yao, K., Bergamasco, M., Scattoni, M. L., & Vogel, A. P. (2023) · The Journal of the Acoustical Society of America · doi:10.1121/10.0020544 · Cited by 38
Steinberg, K. M., Ramachandran, D., Patel, V. C., Shetty, A. C., Cutler, D. J., & Zwick, M. E. (2012) · Molecular Autism · doi:10.1186/2040-2392-3-8 · Cited by 33
Synapse alterations in autism: Review of animal model findings
Zatkova, M., Bakos, J., Hodosy, J., & Ostatnikova, D. (2016) · Biomedical Papers · doi:10.5507/bp.2015.066 · Cited by 27
Sungur, A. Ö., Jochner, M. C. E., Harb, H., Kılıç, A., Garn, H., Schwarting, R. K. W., & Wöhr, M. (2017) · Hippocampus · doi:10.1002/hipo.22741 · Cited by 32
Greene, R. K., Walsh, E. C., Mosner, M. G., & Dichter, G. S. (2018) · Biological Psychology · doi:10.1016/j.biopsycho.2018.12.008 · Cited by 30
“Additionally, SHANK3 has been proposed as candidate gene for ASD (Durand et al., 2007; Pinto et al., 2010).”
BackgroundLee, K., Vyas, Y., Garner, C. C., & Montgomery, J. M. (2019) · Synapse · doi:10.1002/syn.22097 · Cited by 31
Cai, Q., Hosokawa, T., Zeng, M., Hayashi, Y., & Zhang, M. (2019) · Structure · doi:10.1016/j.str.2019.11.018 · Cited by 29
“Many point mutations of SHANK3 have been identified in autism patients or individuals with intellectual disabilities (Durand et al., 2007; Gauthier et al., 2009; Moessner et al., 2007).”
BackgroundModifier genes in SCN1A ‐related epilepsy syndromes
Lange, I., Mulder, F., Slot, R. V. ‘., Sonsma, A. C. M., van Kempen, M. J. A., Nijman, I. J., Ernst, R. F., Knoers, N. V. A. M., Brilstra, E. H., & Koeleman, B. P. C. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1103 · Cited by 30
“Both genes are associated with severe neurodevelopmental disorders (Carvill et al., 2013; Durand et al., 2007).”
BackgroundFaja, S., & Dawson, G. (2017) · Wiley eBooks · doi:10.1002/9781394258932.ch22 · Cited by 33
Ali, F., Shao, L.-X., Gerhard, D. M., Sweasy, K., Pothula, S., Pittenger, C., Duman, R. S., & Kwan, A. C. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0708-6 · Cited by 26
“Studies have brought forth evidence linking SHANK3 to these disorders by finding mutations and copy number variants in individuals with autism spectrum disorder [5, 6], which is confirmed by an extensive screen and meta-analysis [7].”
BackgroundReilly, J., Gallagher, L., Leader, G., & Shen, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242773 · Cited by 31
Knott, R., Johnson, B. P., Tiego, J., Mellahn, O. J., Finlay, A., Kallady, K., Kouspos, M., Sindhu, V. P. M., Hawi, Z., Arnatkevičiūtė, A., et al. (2021) · Molecular Autism · doi:10.1186/s13229-021-00457-3 · Cited by 29
“Copy number variations (CNV’s; Durand et al., 2007; Wang, Xu, Bey, Lee, & Jiang, 2014), de novo mutations (Iossifov et al., 2012; O’Roak et al., 1989; Roak et al., 2011; Sanders et al., 2012), and common genetic variation from Genome-Wide Association Studies (Gaugler et al., 2014; Grove et al.,…”
BackgroundA randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome
Fastman, J., Foss‐Feig, J. H., Frank, Y., Halpern, D. B., Harony‐Nicolas, H., Layton, C., Sandin, S., Siper, P. M., Tang, L., Trelles, M. P., et al. (2021) · Molecular Autism · doi:10.1186/s13229-021-00459-1 · Cited by 27
Criss‐crossing autism spectrum disorder and adult neurogenesis
Bicker, F., Nardi, L., Maier, J., Vasić, V., & Schmeißer, M. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15501 · Cited by 28
SHANK3 conformation regulates direct actin binding and crosstalk with Rap1 signaling
Salomaa, S. I., Miihkinen, M., Kremneva, E., Paatero, I., Lilja, J., Jacquemet, G., Vuorio, J., Antenucci, L., Kogan, K., Nia, F. H., et al. (2021) · Current Biology · doi:10.1016/j.cub.2021.09.022 · Cited by 31
Lactobacillus reuteri normalizes altered fear memory in male Cntnap4 knockout mice
Zhang, W., Huang, J., Gao, F., You, Q.-L., Ding, L., Gong, J., Zhang, M., Ma, R., Zheng, S., Sun, X., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104323 · Cited by 31
Ferhat, A.-T. L. S., Verpy, E., Biton, A., Forget, B., de Chaumont, F., Mueller, F., Sourd, A. L., Coqueran, S., Schmitt, J., Rochefort, C., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1139118 · Cited by 30
“Ferhat Allain-Thibeault†* (1,2,3), Verpy Elisabeth† (1), Biton Anne† (4), Forget Benoît (1), de Chaumont Fabrice (1), Mueller Florian (5), Le Sourd Anne-Marie (1), Coqueran Sabrina (1), Schmitt Julien (6), Rochefort Christelle (6), Rondi-Reig Laure (6), Leboucher Aziliz (1), Boland Anne (7), Fin Bertrand (7), Deleuze…”
BackgroundSelf-citationSleep disturbances in autism spectrum disorder: Animal models, neural mechanisms, and therapeutics
Maurer, J. J., Choi, A., An, I., Sathi, N., & Chung, S. (2023) · Neurobiology of Sleep and Circadian Rhythms · doi:10.1016/j.nbscr.2023.100095 · Cited by 33
Etiological Heterogeneity in Autism Spectrum Disorders
Betancur, C., & Coleman, M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391924-3.00008-9 · Cited by 29
“1 Nonsyndromic/syndromic (Hynes et al., 2010; Marini et al., 2010) ACSL4 acyl-‐CoA synthetase long-‐chain family member 4 Xq22.”
InfluentialSelf-citationStudtmann, K., Ölschläger‐Schütt, J., Buck, F., Richter, D., Sala, C., Bockmann, J., Kindler, S., & Kreienkamp, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088518 · Cited by 25
“Loss of function allels in all three SHANK genes have been associated with either mental retardation or autism in humans [19,20,21].”
BackgroundSelf-citationMasson, E., Maréchal, C. L., Lévy, P., Chuzhanova, N. A., Ruszniewski, P. B., Cooper, D. N., Chen, J., & Férec, C. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.06.006 · Cited by 26
The association of SHANK3 gene polymorphism and autism
Mashayekhi, F., Mizban, N., Bidabadi, E., & Salehi, Z. (2021) · Minerva Pediatrics · doi:10.23736/s2724-5276.16.04539-4 · Cited by 30
A Presynaptic Function of Shank Protein inDrosophila
Wu, S. H., Gan, G., Zhang, Z., Sun, J. Y., Wang, Q., Gao, Z., Li, M., Jin, S., Huang, J., Thomas, U., et al. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0893-17.2017 · Cited by 28
“Mutations in SHANK3 were the first (Durand et al., 2007) and remain one of the most replicated and well-characterized SHANK mutations in human ASD.”
BackgroundCommon Ribs of Inhibitory Synaptic Dysfunction in the Umbrella of Neurodevelopmental Disorders
Rodriguez, R. A., Joya, C., & Hines, R. M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00132 · Cited by 35
“SHANK3 KO mice show abnormal social behaviors, and impairments in learning and memory (Bozdagi et al., 2010).”
BackgroundInfluentialNia, F. H., Woike, D., Kloth, K., Kortüm, F., & Kreienkamp, H. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15014 · Cited by 31
Structure and function of the guanylate kinase-like domain of the MAGUK family scaffold proteins
Zhu, J., Shang, Y., Chen, J., & Zhang, M. (2012) · Frontiers in Biology · doi:10.1007/s11515-012-1244-9 · Cited by 27
“Psd-95 gene disruption in mice induces behavioral and molecular abnormalities reminiscent of ASD and Williams syndrome in humans (Feyder et al., 2010).”
InfluentialCorrelation of mutated gene and signalling pathways in ASD
Apte, M., & Kumar, A. B. (2023) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.03.011 · Cited by 32
Jia, B., Shen, Z., Zhu, S., Huang, J., Liao, Z., Zhao, S., Li, H., Chen, S., Xu, Y., Wang, Y., et al. (2025) · Cell · doi:10.1016/j.cell.2025.07.047 · Cited by 25
Culotta, L., Scalmani, P., Vinci, E., Terragni, B., Sessa, A., Broccoli, V., Mantegazza, M., Boeckers, T. M., & Verpelli, C. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2194-19.2020 · Cited by 28
“…of SHANK3 gene, encoding a scaffold protein of the postsynaptic density (Naisbitt et al., 1999), is the main cause of the PMS neurologic phenotypes (Durand et al., 2007), the wide clinical heterogeneity among PMS patients suggests that the haploinsufficiency of other genes in the 22q13 region,…”
BackgroundSelf-citationLourenço, J., Koukouli, F., & Bacci, A. (2020) · Cortex · doi:10.1016/j.cortex.2020.08.015 · Cited by 27
Šimić, G., Vukić, V., Kopić, J., Krsnik, Ž., & Hof, P. R. (2020) · Biomolecules · doi:10.3390/biom11010002 · Cited by 29
“However, in individuals who do not develop typical cerebral hemisphere torsion [116,117] and associated predilection of the left hemisphere to develop a phonological component of verbal abilities [118,119], there is an increased risk of developing typical positive symptoms of schizophrenia, such as auditory hallucinat…”
BackgroundPoleg, S., Kourieh, E., Ruban, A., Shapira, G., Shomron, N., Barak, B., & Offen, D. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01612-3 · Cited by 34
Varadinova, M. G., & Boyadjieva, N. I. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.09.011 · Cited by 31
Synaptic Plasticity in Mouse Models of Autism Spectrum Disorders
Chung, L., Bey, A. L., & Jiang, Y. (2012) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2012.16.6.369 · Cited by 31
“Molecular defects in SHANK3 were first found in patients with ASD and ID [100].”
BackgroundMedical conditions in autism spectrum disorders
Bolton, P. (2009) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-009-9021-z · Cited by 30
“These include mutations in Neuroligin 3+4 / neurexin 1 [32, 118–124]; Shank3 [89, 125, 126]; Contactin associated protein-like 2 [127]; Reelin [128] and PTEN [77, 79] In addition, ASD has been associated with various microscopic chromosomal abnormalities involving the 15q11-13 region [33–39, 41–47, 49–52, 129–135]; 22…”
BackgroundDNA methylation analysis in constitutional disorders: Clinical implications of the epigenome
Schenkel, L. C., Rodenhiser, D. I., Ainsworth, P., Paré, G., & Sadiković, B. (2016) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1113496 · Cited by 27
Severe white matter damage in SHANK3 deficiency: a human and translational study
Jesse, S., Müller, H., Schoen, M., Asoglu, H., Bockmann, J., Huppertz, H., Rasche, V., Ludolph, A. C., Boeckers, T. M., & Kassubek, J. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50959 · Cited by 31
“PMS is presumed to be a synaptic disorder as the probable disease-defining gene SHANK3 codes for a synaptic protein of the postsynaptic density.(57,58) The results of the current study suggest an additional involvement of the SHANK3 protein in axonal path finding, fiber bundle integrity, and myelin formation given tha…”
BackgroundSelf-citationPosition effect leading to haploinsufficiency in a mosaic ring chromosome 14 in a boy with autism
Castermans, D., Thienpont, B., Volders, K., Crepel, A., Vermeesch, J. R., Schrander-Stumpel, C. T. R. M., de Ven, W. J. M. V., Steyaert, J. G., Creemers, J. W. M., & Devriendt, K. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.71 · Cited by 27
Gene expression in maturing neurons: regulatory mechanisms and related neurodevelopmental disorders.
Ding, B. (2015) · PubMed · Cited by 28
Chong, C. H., Li, Q., Mak, P. H. S., Ng, C. C. P., Leung, E. H. W., Tan, V. H., Chan, A. K. W., McAlonan, G. M., & Chan, S. Y. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0580-9 · Cited by 26
Speech and language phenotype in Phelan-McDermid (22q13.3) syndrome
Brignell, A., Gu, C., Holm, A., Carrigg, B., Sheppard, D. A., Amor, D. J., & Morgan, A. T. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-00761-1 · Cited by 28
A recurrent SHANK3 frameshift variant in Autism Spectrum Disorder
Loureiro, L. O., Howe, J., Reuter, M. S., Iaboni, A., Calli, K., Roshandel, D., Pritišanac, I., Moses, A. M., Forman-Kay, J. D., Trost, B., et al. (2021) · npj Genomic Medicine · doi:10.1038/s41525-021-00254-0 · Cited by 33
“1 was selected as the appropriate transcript for this study as this was the reference sequence used in the original publication of this variant in Durand et al.(36)).”
MethodSelf-citationTassano, E., Gamucci, A., Celle, M. E., Ronchetto, P., Cuoco, C., & Gimelli, G. (2015) · Cytogenetic and Genome Research · doi:10.1159/000431391 · Cited by 29
“Genetic variants of PSD proteins have been associated with cognitive defects or mental illness in humans [Willatt et al., 2005; Durand et al., 2007; Bourgeron, 2009; Hamdan et al., 2009, 2011; Pinto et al., 2010].”
BackgroundNewbury, D. F., Warburton, P., Wilson, N., Bacchelli, E., Carone, S., Lamb, J. A., Maestrini, E., Volpi, E. V., Mohammed, S. N., Baird, G., et al. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32704 · Cited by 28
“These collaborative efforts have enabled the identification of the first nonsyndromic ASD susceptibility genes including SHANK3on chromosome 22q [Durand et al., 2007; Moessner et al., 2007], NRXN1 on chromosome 2p [Kim et al., 2008],NLGN3 andNLGN4 on chromosome X [Jamain et al., 2003; Laumonnier et…”
BackgroundIdentification of two novel Shank3 transcripts in the developing mouse neocortex
Waga, C., Asano, H., Sanagi, T., Suzuki, E., Nakamura, Y., Tsuchiya, A., Itoh, M., Goto, Y., Kohsaka, S., & Uchino, S. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12505 · Cited by 27
Shinoda, Y., Sadakata, T., & Furuichi, T. (2013) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.62.71 · Cited by 28
“Both de novo cnV of SHANK2 [3] and de novo cnV, frameshift mutation, and nonsynonymous SnP of SHANK3 [8] have been reported in aSd and asperger syndrome patients. a recent study show that heterozygote mice with a Shank3 c-terminal deletion, Shank3 (+/ΔC), have enhanced polyubiquitination of Shank3 and nMdar and thereb…”
BackgroundAlternative polyadenylation and differential expression of Shank mRNAs in the synaptic neuropil
Epstein, I., Tushev, G., Will, T. J., Vlatkovic, I., Cajigas, I. J., & Schuman, E. M. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0137 · Cited by 27
“Shank genes have been associated with neurodevelopmental and neuropsychiatric disorders, such as autism spectrum disorders (ASD) and schizophrenia [18–21].”
BackgroundWang, L., Hranilović, D., Wang, K., Lindquist, I. E., Yurcaba, L., Petković, Z. B., Gidaya, N. B., Jernej, B., Hakonarson, H. H., & Bućan, M. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-134 · Cited by 28
Mack, D. L., Guan, X., Wagoner, A. L., Walker, S. J., & Childers, M. K. (2014) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000000141 · Cited by 25
Boutte, D., Calhoun, V. D., Chen, J., Sabbineni, A., Hutchison, K. E., & Liu, J. (2012) · Alcohol · doi:10.1016/j.alcohol.2012.05.002 · Cited by 25
“, 2010) and other neuropsychiatric diseases (Durand et al., 2007).”
BackgroundAssessing the impact of a combined analysis of four common low-risk genetic variants on autism risk
Carayol, J., Schellenberg, G. D., Tores, F., Hager, J., Ziegler, A., & Dawson, G. (2010) · Molecular Autism · doi:10.1186/2040-2392-1-4 · Cited by 24
“Indeed, cases of autism have only rarely been associated with mutations in single genes or with chromosomal duplications or other abnormalities [5-9].”
BackgroundTanabe, Y., Fujita‐Jimbo, E., Momoi, M. Y., & Momoi, T. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13168 · Cited by 28
Xu, Q., Goldstein, J., Wang, P., Gadi, I. K., LaBreche, H. G., Rehder, C. W., Wang, W., McConkie‐Rosell, A., Xu, X., & Jiang, Y. (2016) · Pediatric Research · doi:10.1038/pr.2016.101 · Cited by 26
“This interval overlaps 12 known genes including SHANK3, a causative gene for ASD and a key player in PMS (21,22).”
BackgroundInfluentialSungur, A. Ö., Schwarting, R. K. W., & Wöhr, M. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.09.038 · Cited by 26
Clair, D. S., & Johnstone, M. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2017.0037 · Cited by 24
“Among these genes are NGLN4X [14], SHANK3 [23,24], NRXN1 [25,26], SHANK2 [27], CNTN4 [28–30] and CNTNAP2 [31,32].”
Bukatová, S., Renczés, E., Reichova, A., Filo, J., Sadlonova, A., Mravec, B., Ostatníková, D., Bakoš, J., & Bačová, Z. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03435-6 · Cited by 23
Genetic analysis of the DLGAP1 gene as a candidate gene for schizophrenia
Li, J., Lu, C.-L., Cheng, M.-C., Luu, S.-U., Hsu, S.-H., & Chen, C. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.08.014 · Cited by 28
“In addition, multiple rare mutations in the SHANK3 gene that encodes a scaffolding protein abundant in the PSD of excitatory synapses on dendritic spines were found in patients with autism (Durand et al., 2007; Gauthier et al., 2009; Moessner et al., 2007) and schizophrenia (Gauthier et al., 2010).”
Fischer, I., Shohat, S., Leichtmann‐Bardoogo, Y., Nayak, R., Wiener, G., Rosh, I., Shemen, A., Tripathi, U., Rokach, M., Bar, E., et al. (2024) · Science Advances · doi:10.1126/sciadv.adl4573 · Cited by 25
“In humans, the corresponding mutation leads to a specific disorder on the autistic spectrum, and therefore, studying this mouse model has a greater potential to understand its underlying mechanisms in humans ( 12 , 13 ).”
Background
Metadata
- Authors
- Durand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., Sponheim, E., Goubran-Botros, H., Delorme, R., Chabane, N., Mouren-Simeoni, M.-C., de Mas, P., Bieth, E., Rogé, B., Héron, D., Burglen, L., Gillberg, C., Leboyer, M., & Bourgeron, T.
- Affiliations
- Institut Pasteur (FR)
- Inserm (FR)
- Universität Ulm (DE)
- University of Gothenburg (SE)
- University of Oslo (NO)
- Assistance Publique – Hôpitaux de Paris (FR)
- Université Toulouse - Jean Jaurès (FR)
- Pitié-Salpêtrière Hospital (FR)
- St George's Hospital (GB)
- Corresponding author
- Bourgeron, Thomas
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-12-17
- Volume
- 39
- Issue
- 1
- Pages
- 25-27
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC2082049
- OpenAlex
- W1983194657
- Cited by
- 1,602
- References
- 16
- Citations by year
- 2026: 48 · 2025: 40 · 2024: 75 · 2023: 71 · 2022: 78 · 2021: 91 · 2020: 85 · 2019: 68 · 2018: 81 · 2017: 99 · 2016: 79 · 2015: 96 · 2014: 78 · 2013: 97 · 2012: 114
- FWCI
- 33.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- George Washington University
- Georgetown University
- Children's National Hospital
- European Commission
- Deutsche Forschungsgemeinschaft (SFB 497)
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Fondation de France
- Universitetet i Oslo
- Assistance publique-Hôpitaux de Paris
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- SHANK3, autism spectrum disorder, neuroligins, dendritic spines, synaptic scaffolding, chromosome 22q13, gene dosage sensitivity, language disorders, social communication disorder, Asperger syndrome
- MeSH terms
- Autistic Disorder, Base Sequence, Carrier Proteins, DNA Mutational Analysis, Female, Genetic Testing, Humans, Male, Molecular Sequence Data, Mutation, Nerve Tissue Proteins, Pedigree, In Situ Hybridization, Fluorescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.